サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1650991

バイオプロセス容器の世界市場

Bioprocess Containers

出版日
ページ情報
英文 271 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
バイオプロセス容器の世界市場
出版日: 2025年02月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 271 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

バイオプロセス容器の世界市場は2030年までに343億米ドルに到達

2024年に95億米ドルと推定されるバイオプロセス容器の世界市場は、2024年から2030年にかけてCAGR 23.7%で成長し、2030年には343億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである2Dバイオプロセス容器は、CAGR 27.1%を記録し、分析期間終了時には223億米ドルに達すると予測されます。3Dバイオプロセス容器分野の成長率は、分析期間のCAGRで19.0％と推定されます。

米国市場は28億米ドル、中国はCAGR 22.6％で成長予測

米国のバイオプロセス容器市場は、2024年に28億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに51億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは22.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ21.5％と19.4％と予測されています。欧州では、ドイツがCAGR約15.6%で成長すると予測されています。

世界のバイオプロセス容器市場- 主要動向と促進要因のまとめ

バイオプロセス容器はバイオマニュファクチャリングの情勢をどのように形成しているか？

バイオプロセス容器は、バイオマニュファクチャリングの分野で重要なコンポーネントとして登場し、生物学的マテリアルの取り扱い、保管、処理方法に革命をもたらしています。これらの容器は一般的に高度なポリマーから作られており、特に医薬品、ワクチン、生物製剤の製造におけるバイオプロセスの複雑なニーズを安全かつ効率的に管理するように設計されています。従来のステンレス製システムとは異なり、バイオプロセス容器は柔軟性のあるシングルユースの代替品を提供することで、二次汚染のリスクを大幅に軽減し、製造工程を合理化します。これは、無菌状態を維持し、製品の完全性を確保することが最も重要な、繊細な生物学的製剤の製造において特に重要です。また、バイオプロセス容器の採用は、モジュール式でスケーラブルなバイオ製造施設の増加傾向をサポートし、製造プロセスの柔軟性と効率性を高めることを可能にします。生物製剤や個別化医療の需要が高まり続ける中、バイオプロセス容器は最新のバイオマニュファクチャリングのニーズに応えるために、ますます必要不可欠なものとなってきています。

バイオプロセス容器が業界で最もインパクトを与えているのはどこですか？

バイオプロセス容器は、バイオマニュファクチャリング業界において、いくつかの重要な分野で大きなインパクトを与えています。製薬分野では、モノクローナル抗体、ワクチン、その他の生物製剤の製造に広く使用されており、シングルユースであるため、バッチ間の洗浄や滅菌の必要がなく、製造プロセスが簡素化されます。これにより、ダウンタイムが短縮されるだけでなく、全体的な生産効率も向上し、汚染のリスクも軽減されます。バイオテクノロジー業界では、生物学的材料の無菌性と品質の維持が重要である細胞治療や遺伝子治療の開発・生産にもバイオプロセス容器が活用されています。さらに、バイオプロセス容器は、パイロットスケールと商業スケールの両方でバイオ医薬品の生産に使用されており、様々な生産量に簡単に適応できるスケーラブルなソリューションを提供しています。バイオプロセス容器は、製造受託機関（CMO）にも使用されており、複数の顧客の多様な生産要求に応えるために必要な柔軟性とコスト効率を提供しています。このように、バイオプロセス容器は、バイオマニュファクチャリングプロセスを最適化し、高品質な生物学的製剤の生産をサポートする上で、非常に重要な役割を果たしています。

なぜバイオプロセス容器はバイオマニュファクチャリングで人気を集めているのでしょうか？

バイオマニュファクチャリングにおけるバイオプロセス容器の人気の高まりは、より柔軟で、効率的で、スケーラブルな生産方法への業界のシフトと密接な関係があります。バイオプロセス容器が採用される主な理由のひとつは、生物学的製剤の生産において重要な要素であるコンタミネーションのリスクを軽減できることです。シングルユースであるため、洗浄や滅菌の必要がなく、時間の節約やオペレーションコストの削減だけでなく、バッチ間の交差汚染のリスクも最小限に抑えることができます。これは、複数の製品を生産する施設や、非常に敏感な生物学的物質を扱う施設では特に重要です。さらに、バイオプロセス容器は生産における柔軟性を向上させるため、メーカーはインフラを大幅に変更することなく、需要や生産要件の変化に迅速に対応することができます。また、バイオプロセス容器のモジュール性は、必要に応じて簡単にスケールアップやスケールダウンができる、より小型で機敏な製造設備への動向をサポートします。さらに、シングルユースシステムは、廃棄が容易で環境への影響も少ないため、規制や持続可能性への圧力が高まる中、バイオプロセス容器は魅力的な選択肢となります。バイオプロセス容器は、バイオマニュファクチャリング業界が進化し続ける中、より効率的で、適応性が高く、持続可能な生産方法を可能にする重要な役割を果たしています。

バイオプロセス容器市場の成長を促進する要因は？

バイオプロセス容器市場の成長は、いくつかの重要な要因によって牽引されています。主な促進要因は、高度に管理された無菌の製造環境を必要とするモノクローナル抗体、ワクチン、細胞・遺伝子治療などの生物製剤に対する需要の高まりです。バイオプロセス容器は、生物製剤製造の厳しい要件を満たしながら、汚染リスクを低減する柔軟でコスト効率の高いソリューションを提供します。生物学的製剤製造におけるシングルユース技術への動向も重要な要因の一つです。また、製造受託機関（CMO）の拡大と、適応性と拡張性に優れた製造ソリューションへのニーズも、市場成長に寄与しています。バイオプロセス容器により、CMOはさまざまな顧客のために複数の製品の製造を効率的に管理できるようになるからです。さらに、より耐久性が高く堅牢な容器材料の開発など、バイオプロセス技術の進歩がバイオプロセス容器の性能と信頼性を高め、その採用をさらに促進しています。水とエネルギーの消費削減に重点を置いたバイオ製造における持続可能性への注目の高まりも、バイオプロセス容器が業界の持続可能性目標に合致していることから、バイオプロセス容器市場の成長を後押ししています。これらの要因が相まって、バイオプロセス容器はバイオマニュファクチャリングの未来に欠かせない存在となっています。

セグメント

タイプ（2Dバイオプロセス容器、3Dバイオプロセス容器、その他のタイプ）、用途（上流工程、下流工程、プロセス開発）、最終用途（製薬・バイオファーマ企業、CRO・CMO、学術・研究機関）

調査対象企業の例（全38件）

  • Danaher Corporation
  • Fenner PLC
  • Fluids Control
  • GE Healthcare
  • Lonza Group AG
  • Meissner Filtration Products
  • Merck KgaA
  • Rim Bio Inc.
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP10730

Global Bioprocess Containers Market to Reach US$34.3 Billion by 2030

The global market for Bioprocess Containers estimated at US$9.5 Billion in the year 2024, is expected to reach US$34.3 Billion by 2030, growing at a CAGR of 23.7% over the analysis period 2024-2030. 2D Bioprocess Containers, one of the segments analyzed in the report, is expected to record a 27.1% CAGR and reach US$22.3 Billion by the end of the analysis period. Growth in the 3D Bioprocess Containers segment is estimated at 19.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 22.6% CAGR

The Bioprocess Containers market in the U.S. is estimated at US$2.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.1 Billion by the year 2030 trailing a CAGR of 22.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 21.5% and 19.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.6% CAGR.

Global Bioprocess Containers Market - Key Trends and Drivers Summarized

How Are Bioprocess Containers Shaping the Landscape of Biomanufacturing?

Bioprocess containers have emerged as a critical component in the field of biomanufacturing, revolutionizing how biological materials are handled, stored, and processed. These containers, typically made from advanced polymers, are designed to safely and efficiently manage the complex needs of bioprocessing, particularly in the production of pharmaceuticals, vaccines, and biologics. Unlike traditional stainless steel systems, bioprocess containers offer a flexible, single-use alternative that significantly reduces the risk of cross-contamination and streamlines the production process. This is especially important in the production of sensitive biological products, where maintaining sterility and ensuring product integrity are paramount. The adoption of bioprocess containers also supports the growing trend towards modular and scalable biomanufacturing facilities, allowing for greater flexibility and efficiency in the production process. As the demand for biologics and personalized medicine continues to rise, bioprocess containers are becoming increasingly essential in meeting the needs of modern biomanufacturing.

Where Are Bioprocess Containers Making the Most Impact in the Industry?

Bioprocess containers are making a substantial impact across several key areas within the biomanufacturing industry. In the pharmaceutical sector, they are used extensively for the production of monoclonal antibodies, vaccines, and other biologics, where their single-use nature simplifies the production process by eliminating the need for cleaning and sterilization between batches. This not only reduces downtime but also enhances overall production efficiency and reduces the risk of contamination. The biotechnology industry is also leveraging bioprocess containers in the development and production of cell and gene therapies, where maintaining the sterility and quality of biological materials is critical. Additionally, bioprocess containers are used in the production of biopharmaceuticals at both the pilot and commercial scales, providing a scalable solution that can easily be adapted to different production volumes. The use of bioprocess containers in contract manufacturing organizations (CMOs) is another area of impact, where they offer the flexibility and cost-effectiveness needed to meet the diverse production demands of multiple clients. Across these applications, bioprocess containers are proving to be invaluable in optimizing the biomanufacturing process and supporting the production of high-quality biological products.

Why Are Bioprocess Containers Gaining Popularity in Biomanufacturing?

The growing popularity of bioprocess containers in biomanufacturing is closely linked to the industry's shift towards more flexible, efficient, and scalable production methods. One of the primary reasons for their adoption is the ability of bioprocess containers to reduce the risk of contamination, a critical factor in the production of biological products. Their single-use nature eliminates the need for cleaning and sterilization, which not only saves time and reduces operational costs but also minimizes the risk of cross-contamination between batches. This is particularly important in facilities that produce multiple products or work with highly sensitive biological materials. Moreover, bioprocess containers offer greater flexibility in production, allowing manufacturers to quickly adapt to changes in demand or production requirements without the need for significant infrastructure changes. The modularity of bioprocess containers also supports the trend towards smaller, more agile manufacturing facilities that can be easily scaled up or down as needed. Additionally, the ease of disposal and reduced environmental impact associated with single-use systems make bioprocess containers an attractive option in the context of increasing regulatory and sustainability pressures. As the biomanufacturing industry continues to evolve, bioprocess containers are playing a key role in enabling more efficient, adaptable, and sustainable production practices.

What Factors Are Driving the Growth of the Bioprocess Containers Market?

The growth in the bioprocess containers market is driven by several key factors. A major driver is the rising demand for biologics, including monoclonal antibodies, vaccines, and cell and gene therapies, which require highly controlled and sterile manufacturing environments. Bioprocess containers offer a flexible and cost-effective solution that meets the stringent requirements of biologic production while reducing the risk of contamination. The trend towards single-use technologies in biomanufacturing is another significant factor, as these systems provide greater flexibility, reduce capital expenditures, and simplify regulatory compliance. The expansion of contract manufacturing organizations (CMOs) and their need for adaptable and scalable production solutions is also contributing to the market growth, as bioprocess containers allow CMOs to efficiently manage the production of multiple products for different clients. Additionally, ongoing advancements in bioprocessing technology, including the development of more durable and robust container materials, are enhancing the performance and reliability of bioprocess containers, further driving their adoption. The increasing focus on sustainability in biomanufacturing, with an emphasis on reducing water and energy consumption, is also supporting the growth of the bioprocess containers market, as these systems align with the industry's sustainability goals. Together, these factors are propelling the market forward, making bioprocess containers an integral part of the future of biomanufacturing.

SCOPE OF STUDY:

The report analyzes the Bioprocess Containers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (2D Bioprocess Containers, 3D Bioprocess Containers, Other Types); Application (Upstream Processes, Downstream Processes, Process Development); End-Use (Pharma & Biopharma Companies, CROs & CMOs, Academic & Research Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 38 Featured) -

  • Danaher Corporation
  • Fenner PLC
  • Fluids Control
  • GE Healthcare
  • Lonza Group AG
  • Meissner Filtration Products
  • Merck KgaA
  • Rim Bio Inc.
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Bioprocess Containers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surging Biopharmaceutical Production Propels Growth of Bioprocess Containers
    • Single-Use Technologies Spur Demand for Disposable Bioprocess Containers
    • Here's the Story: How Personalized Medicine Expands the Addressable Market for Bioprocess Containers
    • Rising Demand for Flexible Manufacturing Accelerates Adoption of Bioprocess Containers
    • Innovations in Sterility and Contamination Control Drive Growth in High-Performance Bioprocess Containers
    • Advances in Material Science Expand Opportunities in Durable and Resilient Bioprocess Containers
    • Pharmaceutical Cold Chain Logistics Throws the Spotlight on Temperature-Controlled Bioprocess Containers
    • Growing Focus on Sustainability Generates Demand for Eco-friendly Bioprocess Containers
    • Increased Outsourcing in Biomanufacturing Fuels Demand for Bioprocess Containers
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Upstream Processes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Upstream Processes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Downstream Processes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Downstream Processes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Process Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Process Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for 2D Bioprocess Containers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for 2D Bioprocess Containers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for 3D Bioprocess Containers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for 3D Bioprocess Containers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Pharma & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for CROs & CMOs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 16: World 6-Year Perspective for CROs & CMOs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World 6-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 19: World Bioprocess Containers Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Bioprocess Containers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Bioprocess Containers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • JAPAN
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • CHINA
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • EUROPE
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Bioprocess Containers by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Bioprocess Containers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • FRANCE
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • GERMANY
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • UNITED KINGDOM
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Bioprocess Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Bioprocess Containers by Application - Upstream Processes, Downstream Processes and Process Development - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Bioprocess Containers by Application - Percentage Breakdown of Value Sales for Upstream Processes, Downstream Processes and Process Development for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Bioprocess Containers by Type - 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Bioprocess Containers by Type - Percentage Breakdown of Value Sales for 2D Bioprocess Containers, 3D Bioprocess Containers and Other Types for the Years 2025 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Bioprocess Containers by End-Use - Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Bioprocess Containers by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, CROs & CMOs and Academic & Research Institutes for the Years 2025 & 2030

IV. COMPETITION